Winston Medical Supply Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	700.07	695.08	709.07	606.52	536.53
Revenue Growth (YoY)	0.72%	-1.97%	16.91%	13.05%	6.22%
Cost of Revenue	396.31	379.24	361.48	342.07	299.13
Gross Profit	303.77	315.84	347.6	264.45	237.39
Selling, General & Admin	153.19	147.16	142.87	122.89	113.21
Research & Development	8.76	9.43	8.64	7	7.72
Operating Expenses	161.95	156.59	151.5	128.59	122.11
Operating Income	141.82	159.26	196.1	135.86	115.29
Interest Expense	-1.19	-1.17	-1.53	-1.06	-1.84
Interest & Investment Income	-	2.85	2.01	0.4	0.17
Currency Exchange Gain (Loss)	-	0.39	-0.19	0.08	-0.2
Other Non Operating Income (Expenses)	5.5	3.96	3.46	6.11	3.42
EBT Excluding Unusual Items	146.13	165.29	199.85	141.4	116.84
Gain (Loss) on Sale of Assets	-	-1.11	-1.03	-	-0.25
Pretax Income	146.13	164.18	198.82	141.4	116.59
Income Tax Expense	28.84	32.59	40.06	30.14	24.46
Earnings From Continuing Operations	117.29	131.59	158.76	111.26	92.13
Net Income to Company	117.29	131.59	158.76	111.26	92.13
Net Income	117.29	131.59	158.76	111.26	92.13
Net Income to Common	117.29	131.59	158.76	111.26	92.13
Net Income Growth	-10.87%	-17.11%	42.69%	20.77%	-7.58%
Shares Outstanding (Basic)	18	18	18	18	18
Shares Outstanding (Diluted)	18	18	18	18	18
Shares Change (YoY)	-0.11%	-0.04%	-	0.27%	3.93%
EPS (Basic)	6.37	7.15	8.62	6.04	5.04
EPS (Diluted)	6.35	7.12	8.58	6.01	4.99
EPS Growth	-10.81%	-17.02%	42.76%	20.44%	-11.21%
Free Cash Flow	138.49	130.24	196.41	118.49	141.4
Free Cash Flow Per Share	7.50	7.04	10.62	6.41	7.67
Dividend Per Share	-	7.000	6.600	5.000	4.000
Dividend Growth	-	6.06%	32.00%	25.00%	33.33%
Gross Margin	43.39%	45.44%	49.02%	43.60%	44.25%
Operating Margin	20.26%	22.91%	27.66%	22.40%	21.49%
Profit Margin	16.75%	18.93%	22.39%	18.34%	17.17%
Free Cash Flow Margin	19.78%	18.74%	27.70%	19.54%	26.36%
EBITDA	168.62	185.07	221.25	171.37	149.31
EBITDA Margin	24.09%	26.63%	31.20%	28.26%	27.83%
D&A For EBITDA	26.81	25.82	25.15	35.51	34.03
EBIT	141.82	159.26	196.1	135.86	115.29
EBIT Margin	20.26%	22.91%	27.66%	22.40%	21.49%
Effective Tax Rate	19.73%	19.85%	20.15%	21.31%	20.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.